Blocking CIRP, either by neutralizing antibody or the use of CIRP−/− mice, showed decreased inflammation and improved survival in several rodent models of inflammatory diseases including hemorrhagic shock and sepsis (Qiang et al. 2013; Godwin et al. 2015; Cen et al. 2016). The gene discussed is CIRBP; the disease is Shock.